Publications

5808 Results

Phase III study comparing sequential chemotherapy (CT) and radiotherapy (RT) to RT for resected and negative margins squamous cell carcinoma of the head and neck: Intergroup study #0034.

Authors
M Al-Sarraf;CB Scott;K Ahmad;JG Schwade;D Schuller;GE Laramore;J Jacobs
Journal / Conference
Proc of the American Society of Clinical Oncology 11:242(#778)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Unappreciated impact of potentially "curative" surgery (pcs) in multi-modality head and neck (h+n) trials upon sample size requirements.

Authors
TF Pajak;JR Jacobs
Journal / Conference
International Conference on Head and Neck cancer-San Francisco :121(#283)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Chemotherapy as predector of compliance.

Authors
JR Jacobs;RA Casiano;DE Schulller;TF Pajak;GE Laramore;M Al-Sarraf
Journal / Conference
International Conference on Head and Neck Cancer 62(#49)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Is a surgical resection leaving positive margins of benefit to the patient with locally-advanced squamous cell carcinoma of hte head and neck?

Authors
GE Laramore;CB Scott;DE Schuller;RE Haselow;TJ Ervin;R Wheeler;M Al-Sarraf;RA Gahbauer;JR Jacobs;JG Schwade;BH Campbell
Journal / Conference
Proc of the 34th Annual ASTRO Meeting 24:173(#83)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on intergroup study 0034.

Authors
WK Hong
Journal / Conference
International Journal of Radiation Oncology Biology Physics 23(4):885-886
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Authors
JP Pignon;R Arriagada;DC Ihde;DH Johnson;MC Perry;RL Souhami;Ola Brodin;RA Joss;MS Kies;B Lebeau;T Onoshi;K Osterlind;MHN Tattersall;H Wagner;JJ Crowley;JG Mira
Journal / Conference
New England Journal of Medicine 327:1618-1624
Year
1992
Research Committee(s)
Lung
Study Number(s)
SWOG-7924

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.

Authors
J Crowley;S Green;CK Osborne
Journal / Conference
The Lancet 339(8784):1-5/71-85
Year
1992
Research Committee(s)
Breast

Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of the literature.

Authors
K Antman;L Ryan;E Borden;WC Wood;HL Lerner;JM Corson;R Carey;H Sult;S Balcerzak;A Elias;L Baker
Journal / Conference
Adjuvant Therapy of Cancer, SE Salmon (ed.)W.B. Saunders Co VI:529-542
Year
1991
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.

Authors
DD Von Hoff;R Kronmal;SE Salmon;J Turner;JB Green;JS Bonorris;EL Moorhead;HE Hynes;RP Pugh;RJ Belt;DS Alberts
Journal / Conference
Cancer 67(1):20-27
Year
1991
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8092

A randomized trial of cis-platinum, vinblastine, and bleomycin vs. vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: A Southwest Oncology Group study.

Authors
AJ Wozniak;MK Samson;NT Shah;ED Crawford;CD Ford;SJ Altman;RL Stephens;RB Natale;BA Bouroncle;B Blumenstein;GD Cummings
Journal / Conference
JCO 9(1):70-76
Year
1991
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8110